Gene · 2867
Papers2,791
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,791
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of gut microbiota and associated mechanisms on postprandial glucose levels in patients with diabetes. | J Transl Int Med | 2023 | 38130636 | PubTator, text mining | PubMed |
| Maternal Blood Lipid Biomarkers of Oligodendrocyte Pathology to Predict Fetal Alcohol Spectrum Disorders. | Obstet Gynecol Res | 2023 | 38125903 | PubTator, text mining | PubMed |
| SCFAs switch stem cell fate through HDAC inhibition to improve barrier integrity in 3D intestinal organoids from patients with obesity. | iScience | 2023 | 38125020 | PubTator, text mining | PubMed |
| New insights in the metabolic function related to gut microbiota in the process of liver regeneration. | Hepatobiliary Surg Nutr | 2023 | 38115924 | PubTator, text mining | PubMed |
| The gut-lung axis in critical illness: microbiome composition as a predictor of mortality at day 28 in mechanically ventilated patients. | BMC Microbiol | 2023 | 38110878 | PubTator, text mining | PubMed |
| Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner. | Elife | 2023 | 38085667 | PubTator, text mining | PubMed |
| Changes of the gut microbiota composition and short chain fatty acid in patients with atrial fibrillation. | PeerJ | 2023 | 38084144 | PubTator, text mining | PubMed |
| Butyrate reduces adherent-invasive E. coli-evoked disruption of epithelial mitochondrial morphology and barrier function: involvement of free fatty acid receptor 3. | Gut Microbes | 2023 | 38078655 | PubTator, text mining | PubMed |
| Alveolar macrophage modulation via the gut-lung axis in lung diseases. | Front Immunol | 2023 | 38077401 | PubTator, text mining | PubMed |
| The relationship between atrial fibrillation and NLRP3 inflammasome: a gut microbiota perspective. | Front Immunol | 2023 | 38077349 | PubTator, text mining | PubMed |
| The causal relationship between gut microbiota and leukemia: a two-sample Mendelian randomization study. | Front Microbiol | 2023 | 38075916 | PubTator, text mining | PubMed |
| Apocynum venetum leaf extract alleviated doxorubicin-induced cardiotoxicity by regulating organic acid metabolism in gut microbiota. | Front Pharmacol | 2023 | 38074154 | PubTator, text mining | PubMed |
| Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms. | Gut Microbes | 2023 | 38073096 | PubTator, text mining | PubMed |
| Unravelling the mechanism of neurotensin recognition by neurotensin receptor 1. | Nat Commun | 2023 | 38071229 | PubTator, text mining | PubMed |
| Intestinal Microbiota and Metabolomics Reveal the Role of Auricularia delicate in Regulating Colitis-Associated Colorectal Cancer. | Nutrients | 2023 | 38068869 | PubTator, text mining | PubMed |
| Study on Immunoregulatory Effects of Fucoidan from Sargassum graminifolium In Vivo and Immunoactivation Activity of Its Fecal Fermentation Products Using Co-Culture Model. | Molecules | 2023 | 38067525 | PubTator, text mining | PubMed |
| Gut liver brain axis in diseases: the implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 38057297 | PubTator, text mining | PubMed |
| 3-(4-Hydroxy-3-methoxyphenyl) propionic acid contributes to improved hepatic lipid metabolism via GPR41. | Sci Rep | 2023 | 38040866 | PubTator, text mining | PubMed |
| Impact of intestinal microenvironments in obesity and bariatric surgery on shaping macrophages. | Immunometabolism (Cobham) | 2023 | 38037591 | PubTator, text mining | PubMed |
| Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease. | Tzu Chi Med J | 2023 | 38035056 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2867/papers?page=16